Abstract
Autoantibodies against glutamate receptors, first reported in Rasmussen encephalitis, have been observed in other focal epilepsies, central nervous system ischemic infarcts, transient ischemic attacks, sporadic olivopontocerebellar atrophy, systemic lupus erythematosus, and paraneoplastic encephalopathies. The detection of glutamate receptor autoantibodies is not useful in the evaluation of Rasmussen encephalitis but may be a biomarker for brain ischemia, and it is helpful in diagnosing certain paraneoplastic encephalopathies. Passive transfer of glutamate receptor autoantibodies from patients with systemic lupus erythematosus or paraneoplastic encephalopathy suggests that glutamate receptor autoantibodies can actively contribute to neurologic dysfunction.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 589-592 |
| Number of pages | 4 |
| Journal | Archives of Neurology |
| Volume | 65 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2008 |
Fingerprint
ASJC Scopus subject areas
- Neuroscience(all)
Cite this
Diagnostic and pathogenic significance of glutamate receptor autoantibodies. / Pleasure, David E.
In: Archives of Neurology, Vol. 65, No. 5, 05.2008, p. 589-592.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Diagnostic and pathogenic significance of glutamate receptor autoantibodies
AU - Pleasure, David E
PY - 2008/5
Y1 - 2008/5
N2 - Autoantibodies against glutamate receptors, first reported in Rasmussen encephalitis, have been observed in other focal epilepsies, central nervous system ischemic infarcts, transient ischemic attacks, sporadic olivopontocerebellar atrophy, systemic lupus erythematosus, and paraneoplastic encephalopathies. The detection of glutamate receptor autoantibodies is not useful in the evaluation of Rasmussen encephalitis but may be a biomarker for brain ischemia, and it is helpful in diagnosing certain paraneoplastic encephalopathies. Passive transfer of glutamate receptor autoantibodies from patients with systemic lupus erythematosus or paraneoplastic encephalopathy suggests that glutamate receptor autoantibodies can actively contribute to neurologic dysfunction.
AB - Autoantibodies against glutamate receptors, first reported in Rasmussen encephalitis, have been observed in other focal epilepsies, central nervous system ischemic infarcts, transient ischemic attacks, sporadic olivopontocerebellar atrophy, systemic lupus erythematosus, and paraneoplastic encephalopathies. The detection of glutamate receptor autoantibodies is not useful in the evaluation of Rasmussen encephalitis but may be a biomarker for brain ischemia, and it is helpful in diagnosing certain paraneoplastic encephalopathies. Passive transfer of glutamate receptor autoantibodies from patients with systemic lupus erythematosus or paraneoplastic encephalopathy suggests that glutamate receptor autoantibodies can actively contribute to neurologic dysfunction.
UR - http://www.scopus.com/inward/record.url?scp=43549126023&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=43549126023&partnerID=8YFLogxK
U2 - 10.1001/archneur.65.5.589
DO - 10.1001/archneur.65.5.589
M3 - Article
C2 - 18474732
AN - SCOPUS:43549126023
VL - 65
SP - 589
EP - 592
JO - Archives of Neurology
JF - Archives of Neurology
SN - 0003-9942
IS - 5
ER -